239 related articles for article (PubMed ID: 18001625)
1. Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions.
Hennekens CH
Curr Atheroscler Rep; 2007 Nov; 9(5):409-16. PubMed ID: 18001625
[TBL] [Abstract][Full Text] [Related]
2. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
3. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
4. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
[TBL] [Abstract][Full Text] [Related]
5. Aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Annu Rev Public Health; 1997; 18():37-49. PubMed ID: 9143711
[TBL] [Abstract][Full Text] [Related]
6. Aspirin in the primary prevention of cardiovascular disease: current knowledge and future research needs.
Hennekens CH; Dalen JE
Trends Cardiovasc Med; 2014 Nov; 24(8):360-6. PubMed ID: 25444455
[TBL] [Abstract][Full Text] [Related]
7. Aspirin in the treatment and prevention of cardiovascular disease.
Gaziano JM; Skerrett PJ; Buring JE
Haemostasis; 2000; 30 Suppl 3():1-13. PubMed ID: 11182624
[TBL] [Abstract][Full Text] [Related]
8. The role of aspirin in cardiovascular diseases--forgotten benefits?
Williams A; Hennekens CH
Expert Opin Pharmacother; 2004 Jan; 5(1):109-15. PubMed ID: 14680440
[TBL] [Abstract][Full Text] [Related]
9. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am Heart J; 1999 Apr; 137(4 Pt 2):S9-S13. PubMed ID: 10097241
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cardiovascular disease: risks and benefits of aspirin.
Buring JE; Hennekens CH
J Gen Intern Med; 1990; 5(5 Suppl):S54-7. PubMed ID: 2231066
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
12. An update on aspirin in the primary prevention of cardiovascular disease.
Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
[TBL] [Abstract][Full Text] [Related]
13. Aspirin in chronic cardiovascular disease and acute myocardial infarction.
Hennekens CH
Clin Cardiol; 1990 Mar; Suppl 5():V62-6; discussion V67-72. PubMed ID: 2182244
[TBL] [Abstract][Full Text] [Related]
14. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
Aronow WS
Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
[TBL] [Abstract][Full Text] [Related]
16. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
[TBL] [Abstract][Full Text] [Related]
18. Aspirin use for primary prevention in elderly patients.
Terrosu P
Monaldi Arch Chest Dis; 2016 Jun; 84(1-2):728. PubMed ID: 27374042
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.
Aronow WS
Geriatrics; 2007 Apr; 62(4):12-24. PubMed ID: 17408314
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
